4.8 Article

MOF@COF nanocapsule for the enhanced microwave thermal-dynamic therapy and anti-angiogenesis of colorectal cancer

期刊

BIOMATERIALS
卷 283, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2022.121472

关键词

MOF@COF; Microwave sensitization; Dynamic therapy; Thermal therapy; Tumor anti-angiogenesis

资金

  1. National Key R&D Program of China [2020YFE0100200]
  2. National Natural Science Foundation of China [U20A20335, 81971745, 91859201, 61975214, 61961033]
  3. Beijing Natural Science Foundation [2202057, 7212208, 4202075]
  4. Beijing New Star Program of Science and Technology [Z191100001119042]
  5. International Partnership Program of Chinese Academy of Science [1A1111KYSB20190072]
  6. Sichuan Science and Technology Program [2020YFSY0018]

向作者/读者索取更多资源

This study proposes an integrated strategy derived from MOF@COF for remarkably augmenting single MWTT to reduce tumor recurrence.
Microwave thermal therapy (MWTT) shows great prospect in cancer treatments due to its non-invasive or minimally invasive nature and deep penetration through the tissue. However, incomplete ablation and elevated expression of many pro-tumor angiogenesis after MWTT (e.g., vascular endothelial growth factor, VEGF) induced tumor recurrence still remains an obstacle, especially in some tumors prone to recurrence and metastasis, such as colorectal cancer. Herein, we propose a nanocapsule of covalent organic framework cladding metal organic framework (MOF@COF) with microwave (MW) thermal-dynamic sensitization and co-action of tumor anti-angiogenesis. The MOF of Bi-Mn-porphyrin (BM) is designed as MW sensitizer to generate cytotoxic O-1(2) and heat for microwave dynamic therapy (MWDT) synergistic MWTT. The COF is covalently coated on BM for further augmenting these two sensitization properties, as well as loading hydrophobic inhibitor of Apatinib to down-regulate the expression of VEGF for inhibiting tumor recurrence. Furthermore, the contained Bi and porphyrin endow system with CT and fluorescence imaging (FI) capabilities. In vivo experiments verify that this combi-nation therapy significantly impairs the growth of colorectal cancer with no recurrent carcinoma. Therefore, our work presents an integrated strategy derived from MOF@COF for remarkably augmenting single MWTT to reduce tumor recurrence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据